NCT05103891 2021-12-01Relative Bioavailability of Binimetinib 3 x 15 mg and 45 mg FormulationsPierre Fabre MedicamentPhase 1 Unknown14 enrolled
NCT05097378 2021-10-28PREMIUMCambridge University Hospitals NHS Foundation TrustPhase 2 Unknown45 enrolled